Doxepin Hydrochloride

CHEMBL1628234 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
315.8 g/mol
LogP
Phase
4

A hydrochloride salt form of doxepin used to treat depression, anxiety, and sleep disorders. It exerts its effects by blocking multiple neurotransmitter receptors in the brain.

Peso Molecular

315,8000 g/mol

TPSA

12,50 Ų

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCC=C1c2ccccc2COc2ccccc21.Cl

InChI

InChI=1S/C19H21NO.ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19;/h3-6,8-12H,7,13-14H2,1-2H3;1H

Molecular Formula

C19H22ClNO

HBD / HBA

1 / 2

Ligações Rotacionáveis

3

Átomos Pesados

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A hydrochloride salt form of doxepin used to treat depression, anxiety, and sleep disorders. It exerts its effects by blocking multiple neurotransmitter receptors in the brain.

Yes, Doxepin Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1628234. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6419921. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.